202 related articles for article (PubMed ID: 24599820)
1. Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression.
Qiao Y; Zhang PJ; Lu XT; Sun WW; Liu GL; Ren M; Yan L; Zhang JD
Chin J Integr Med; 2015 Apr; 21(4):259-65. PubMed ID: 24599820
[TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice.
Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C
Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656
[TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice.
Liu Y; Hao F; Zhang H; Cao D; Lu X; Li X
Cell Physiol Biochem; 2013; 32(4):814-26. PubMed ID: 24080960
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
5. Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.
Quesada IM; Lucero A; Amaya C; Meijles DN; Cifuentes ME; Pagano PJ; Castro C
Atherosclerosis; 2015 Oct; 242(2):469-75. PubMed ID: 26298737
[TBL] [Abstract][Full Text] [Related]
6. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
7. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
[TBL] [Abstract][Full Text] [Related]
10. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
[TBL] [Abstract][Full Text] [Related]
11. 20(
Liu C; Feng R; Zou J; Xia F; Wan JB
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623159
[TBL] [Abstract][Full Text] [Related]
12. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
13. Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy.
Wang Y; Ma P; Wang Z; Sun M; Hou B; Xu T; Li W; Yang X; Du G; Ji T; Qiang G
J Ethnopharmacol; 2023 Jan; 300():115680. PubMed ID: 36058479
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of acute myocardial infarction by saponins from flower buds of Panax notoginseng via pro-angiogenesis and anti-apoptosis.
Yang BR; Cheung KK; Zhou X; Xie RF; Cheng PP; Wu S; Zhou ZY; Tang JY; Hoi PM; Wang YH; Lee SM
J Ethnopharmacol; 2016 Apr; 181():50-8. PubMed ID: 26806572
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Panax notoginseng saponins on APP gene transcription in the brain tissue of SAMP8].
Zhong ZG; Lv L; Chai LM; Wu DP; Zhang WY; Huang JL; Gang YW; Li F; Zu B
Zhong Yao Cai; 2011 Jan; 34(1):77-80. PubMed ID: 21818973
[TBL] [Abstract][Full Text] [Related]
16. Panax notoginseng saponins promote hair follicle growth in mice via Wnt/β-Catenin signaling pathway.
Huang D; Gong ZY; Liu SC; Zheng XP; Kyaw KM; Lin BJ
Chem Biol Drug Des; 2023 Jun; 101(6):1416-1424. PubMed ID: 36866966
[TBL] [Abstract][Full Text] [Related]
17. Panax notoginseng saponins promote endothelial progenitor cell angiogenesis via the Wnt/β-catenin pathway.
Zhu P; Jiang W; He S; Zhang T; Liao F; Liu D; An X; Huang X; Zhou N
BMC Complement Med Ther; 2021 Feb; 21(1):53. PubMed ID: 33557814
[TBL] [Abstract][Full Text] [Related]
18. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.
Du YG; Wang LP; Qian JW; Zhang KN; Chai KF
Chin J Integr Med; 2016 Dec; 22(12):910-917. PubMed ID: 26712211
[TBL] [Abstract][Full Text] [Related]
19. Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions.
Craige SM; Kant S; Reif M; Chen K; Pei Y; Angoff R; Sugamura K; Fitzgibbons T; Keaney JF
Free Radic Biol Med; 2015 Dec; 89():1-7. PubMed ID: 26169727
[TBL] [Abstract][Full Text] [Related]
20. Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis.
Yang Q; Wang P; Cui J; Wang W; Chen Y; Zhang T
J Ethnopharmacol; 2016 Dec; 193():255-265. PubMed ID: 27566197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
